Lanthanide(III) complexes of DOTA-glycoconjugates: a potential new class of lectin-mediated medical imaging agents

The synthesis and characterization of a new class of DOTA (1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane) monoamide-linked glycoconjugates (glucose, lactose and galactose) of different valencies (mono, di and tetra) and their Sm(III), Eu(III) and Gd(III) complexes are reported. The 1H NMR spectrum of Eu(III)-DOTALac2 shows the predominance of a single structural isomer of square antiprismatic geometry of the DOTA chelating moiety and fast rotation about the amide bond connected to the targeting glycodendrimer. The in vitro relaxivity of the Gd(III)-glycoconjugates was studied by 1H nuclear magnetic relaxation dispersion (NMRD), yielding parameters close to those reported for other DOTA monoamides. The known recognition of sugars by lectins makes these glycoconjugates good candidates for medical imaging agents (MRI and gamma scintigraphy).     

Highly cytotoxic iron(II) complexes with pentadentate pyridyl ligands as a new class of anti-tumor agents

The iron(II) complexes and with pentadentate pyridyl ligands are stable under physiological conditions and exhibit higher cytotoxicities toward a series of human carcinoma cell lines than cisplatin; can significantly increase intracellular oxidant levels, cleave supercoiled plasmid DNA in vitro without addition of a reductant and induce apoptotic cell death in human cervical epithelioid carcinoma cells (HeLa) as observed in flow cytometric studies.     

Uranium(VI) sulfilimine complexes: a new class of nitrogen analogues of the uranyl ion

The compound tetraphenylphosphonium tetrachlorooxo-S,S-diphenylsulfiliminatouranium, [Ph4P][UOCl4(NSPh2)], has been prepared in high yield from [Ph4P][UOCl5] and [Ph2S=NSiMe3]. An X-ray structure of this compound shows that the uranium atom has a pseudooctahedral geometry with oxygen and nitrogen atoms in trans positions. The structure of the analogous phosphoriminato complex [Ph4P][UOCl4(NPPh3)] has been determined for comparison. Derivatization of the sulfide group shows that only a limited range of functionalization confers stability toward reduction. The emission spectrum of the first electronic excited state reveals a greatly reduced energy compared with that of the uranyl ion. This red shift in the transition is consistent with the weakening of the U-N bond relative to the U-O bond.     

Triazolotriazines as potential chemotherapeutic agents. VI

Several new 1,2,4-triazolo[4,3-b]triazino[7,6-b]indoles were prepared in anticipation that they would have better chemotherapeutic activities, but in the Screening test none of the Compounds was found to be active.     

Physiologically stable vanadium(IV) porphyrins as a new class of anti-HIV agents

The water soluble oxovanadium(IV) tetraarylporphyrin has demonstrated excellent solution stability against glutathione reduction and high potency (5 microM, 97% inhibition) in inhibiting HIV-1 replication in Hut/CCR5 cells.     

Some uses of transition metal complexes as anti-cancer and anti-HIV agents

The success of the clinical uses of cisplatin, cis-[Pt(II)(NH(3))(2)Cl(2)], has stimulated considerable interest in using other metal complexes as new therapeutic agents. This perspective describes our recent work on several classes of gold(III), platinum(II), ruthenium(II, III, IV), iron(II) and vanadium(IV) complexes for anti-cancer and anti-HIV treatments.     

Rhodium-105 complexes as potential radiotherapeutic agents

Rhodium-105 complexes have been investigated for their suitability as the basis of potential bifunctional chelating agents for therapeutic radiopharmaceuticals. Rhodium-105 is a reactor-produced therapeutic radionuclide that is available in high specific activity. The chemistry and biology of several six-coordinate Rh(III) complexes of the general form [RhCl2L]+, where L is a tetradentate ligand containing at least three thioethers donor atoms, is discussed. The backbone chain length of the acyclic or macrocyclic ligand determines the geometry about the Rh(III) centre (cis vs. trans), with the larger ligands preferentially forming trans-dichloro complexes. The stability of all of the 105Rh complexes is very high (>5 days) and the biological clearance properties of the complexes are consistent with their relative lipophilicities.     

Thermal stability of new vanadyl complexes with flavonoid derivatives as potential insulin-mimetic agents

A series of new complexes of the type VO(OH)L·nH₂O ((1) L: fisetin, n = 3; (2) L: quercetin, n = 2; (3) L: morin, n = 4) were synthesised and characterised by analytical as well as IR and electronic data. The modification evidenced in IR spectra was correlated with the presence of flavonoid as bidentate in all complexes. The electronic reflectance spectra showed the d–d transition characteristic for the square-pyramidal stereochemistry of vanadium (IV) ion. The thermal analysis (TG, DTA) in synthetic air flow elucidated the composition and also the number and nature of the water molecules. The TG curves show three well-separated thermal events. The first corresponds to the water loss at lower temperatures, which is followed by flavonoid derivative decomposition and pyrolysis at higher temperatures. The final product is vanadium (V) oxide.     

(O--N--N)PtX] complexes as a new class of light-emitting materials for electrophosphorescent devices

The synthesis and photophysical properties of the robust Pt(II) emitters [(O--N--N)PtX] (HO--N--N = 6-(2-hydroxyphenyl)-2,2'-bipyridine and its derivatives; X = Cl, Br, I, or -CC-Ph) are reported. Yellow electroluminescent devices based on these materials display a low turn-on voltage (1 cd m(-2) at 4 V) and a high luminance (37000 cd m(-2)). Complex 2e, [(F(t)Bu2O--N--N)PtCl], has the highest thermal stability and gave the best OLED.     

Thermal behaviour of new Cu(II) complexes with Schiff bases functionalised with 1,3,5-triazine moieties as potential antibacterial agents

New complexes of type [Cu(L¹)₂(OH₂)]·4H₂O (1), [Cu(L²)(OH₂)]·0.5H₂O (2) and [Cu₃(L³)₂(OH₂)₃]·0.5H₂O (3) were synthesized by [1 + 1], [1 + 2] and [1 + 3], respectively, template condensation of 2,4,6-triamino-1,3,5-triazine and salicylic aldehyde in the presence of copper(II). The features of complexes have been established from microanalytical, IR and UV–Vis data. The thermal analyses have evidenced the thermal intervals of stability and also the accompanying thermodynamic effects. Processes as water elimination and oxidative degradation of the organic ligands were observed. After water elimination, complexes revealed a similar thermal behaviour. The final product of decomposition was copper(II) oxide as powder X-ray diffraction indicated.     

New dimeric and supramolecular organotin(IV) complexes with a tridentate schiff base as potential biocidal agents

The paper describes the synthesis and structural characterization of six new diorganotin(IV) compounds 1–6, [R₂SnL] and a monoorganotin(IV) derivative, C₄H₉SnClL (7). Here L = N′-(5-bromo-2-oxidobenzylidene)-N-(oxidomethylene)hydrazine ligand with ONO tridentate chelation capability and R = CH₃ (1), C₂H₅ (2), n-C₄H₉ (3), C₆H₅ (4), C₈H₁₇ (5), tert-C₄H₉ (6), The packing diagram offers a supramolecular structure for 1 and a dimeric structure for 4 with distorted square-pyramidal and distorted trigonal geometry, respectively. The different geometry of 1 than 4 can be attributed to the presence of intermolecular non-covalent Sn---O and Sn---H interactions in the former. The antifungal, antibacterial, antiurease and antileishmanial activities of these complexes proved them to be active biologically and may be formulated as new metal-based drugs in future.     

Nitrosubstituted hydroxamate ligands in new triphenyltin(IV) complexes as prospective antimicrobial agents

New triphenyltin(IV) hydroxamate complexes, [Ph₃Sn(4-NO₂CnH)] and [Ph₃Sn(4-NO₂BzH)] have been synthesized by the reactions of Ph₃SnCl with potassium 4-nitrocinnamo hydroxamate [4-NO₂C₆H₄CHCHCONHOK] (KHL¹) and potassium 4-nitro benzohydroxamate [4-NO₂C₆H4CONHOK] (KHL²). The complexes were synthesized in 1:1 molar ratio in MeOH?+?C₆H₆ and characterized by physicochemical and IR, ¹H NMR, and mass spectrometry. The bidentate hydroxamate involving bonding through carbonyl and hydroxamic oxygen (O, O coordination) has been inferred from IR spectra. The electrochemical behavior of complexes has been analyzed. Quasi-irreversible two electron metal-centered cathodic process of type Sn^IV/Sn^II redox couple was indicated by cyclic voltammetric technique. The thermal behavior of 1 and 2 studied by TGA has shown continuous decomposition to yield Sn + 0.5SnO₂ and SnO₂ as final residues. The in vitro antimicrobial activity assays of 1 and 2 against pathogenic Gram-positive bacteria (Bacillus subtilis and Staphylococcus aureus), Gram-negative bacteria (Salmonella typhi and Pseudomonas aeruginosa), and fungi (Aspergillus fumigatus and Alternaria alternata) were done by MIC method. The complexes have exhibited appreciable antimicrobial activity relative to the respective standard Gentamycin and Nystatin drugs.     

Osmium (VI) catalyzed chemoselective oxidation of allylic and benzylic alcohols

A mild and highly chemoselective approach to oxidation of allylic, electron rich/deficient benzylic, and heterocyclic alcohols employing catalytic quantities of K₂[OsO₂(OH)₄] (3 mol %) and chloramine-T (50 mol %) is described. The protocol offers short reaction times (25 min–2 h), controlled oxidation, and tolerance to a variety of substrates. A systematic mechanistic study based on the LC-ESI-MS/MS reveals the presence of imidotriooxoosmium species which further reacts with alcohol to give the oxidized product.     

Heterocyclic thionates as a new class of bridging ligands in oxo-centered triangular cyclopentadienylchromium(III) complexes

The interactions of the benzothiazolate complex, CpCr(CO)(2)(SCSN(C(6)H(4))) (2), and the tetrazole thiolate complex, CpCr(CO)(3)(eta(1)-SCN(4)Ph) (3), with controlled amounts of Me(3)OBF(4) and (MeO)(2)SO(2), respectively, produced the corresponding mu(3)-oxo trinuclear thionate-bridged complexes, [Cp(3)Cr(3)(mu(2)-OH)(mu(3)-O)(mu(2)-eta(2)-SCSN(C(6)H(4)))(2)](5)BF(4) (45%) and [Cp(3)Cr(3)(mu(2)-OH)(mu(3)-O)(mu(2)-eta(2)-SCN(4)Ph)(2)](9)(MeOSO(3)) (53%), together with their respective free dimethylated thiolate ligands, [MeSCSNMe(C(6)H(4))](4)BF(4) and (Me(2)SCN(4)Ph)(8)MeOSO(3). The reaction of 3 with Me(3)OBF(4) resulted in the isolation of a binuclear complex, [Cp(2)Cr(2)(mu-OH)(mu-eta(2)-SCN(4)Ph)(2)](7)BF(4) (43%), and (8)BF(4) (27%). The reaction of the thiopyridine complex, CpCr(CO)(2)(SPy) (4), with I(2) also produced a similar mu(3)-oxo complex 10 (31%), together with CpCrI(2)(THF) (11) and the disulfide (SPy)(2). Similar reactions with 2 and 3 and I(2) yielded species 5 and 7, together with 11 and disulfides derived from their respective ligands. Cyclic voltammograms recorded in solutions of 5 and 9 indicated that the compounds could be reduced and oxidized at very similar potentials. An EPR spectrum characteristic of a compound with axial symmetry was obtained for 9 at 7 K. Single-crystal X-ray diffraction analyses confirmed that species 7 is dinuclear, whereas 5 and 9 are structural trinuclear analogues, each containing a mu(3)-oxo central core.     

Carbohydrate-appended 2,2'-dipicolylamine metal complexes as potential imaging agents

Three discrete carbohydrate-appended 2,2'-dipicolylamine ligands were complexed to the {M(CO)(3)}(+) (M = (99m)Tc/Re) core: 2-(bis(2-pyridinylmethyl)amino)ethyl-beta-d-glucopyranoside (L(1)()), 2-(bis(2-pyridinylmethyl)amino)ethyl-beta-D-xylopyranoside (L(2)()), and 2-(bis(2-pyridinylmethyl)amino)ethyl-alpha-d-mannopyranoside (L(3)). An ethylene spacer is used to separate the carbohydrate moiety and the dipicolylamine (DPA) function in all three ligands. The Re complexes [Re(L(1-3))(CO)(3)]Br were characterized by (1)H and (13)C 1D/2D NMR spectroscopies, which confirmed the pendant nature of the carbohydrate moieties in solution. NMR measurements also established the long-range asymmetric effect of the carbohydrate functions on the chelating portion of the ligand. One analogue, [Re(L(1))(CO)(3)]Cl, was characterized in the solid state by X-ray crystallography. Further characterization was provided by IR spectroscopy, elemental analysis, conductivity, and mass spectrometry. Radiolabeling of L(1)-L(3) with [(99m)Tc(H(2)O)(3)(CO)(3)](+) afforded high yield compounds of identical character to the Re analogues. The radiolabeled compounds were found to be stable toward ligand exchange in the presence of a large excess of either cysteine or histidine over a 24-h period.     

Design of rhenium(I) polypyridine biotin complexes as a new class of luminescent probes for avidin

This paper describes the design of a series of luminescent rhenium(I) polypyridine biotin complexes containing different spacer-arms, [Re(N-N)(CO)3 (py-4-CH2-NH-biotin)](PF6) (py-4-CH2-NH-biotin = 4-(biotinamidomethyl)pyridine; N-N = 1,10-phenanthroline, phen (1a), 3,4,7,8-tetramethyl-1,10-phenanthroline, Me4-phen (2a), 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline, Me2-Ph2-phen (3a), dipyrido[3,2-f:2',3'-h]quinoxaline, dpq (4a)), [Re(N-N)(CO)3 (py-3-CO-NH-en-NH-biotin)](PF6) (py-3-CO-NH-en-NH-biotin = 3-(N-((2-biotinamido)ethyl)amido)pyridine; N-N = phen (1b), Me4-phen (2b), Me2-Ph2-phen (3b), dpq (4b)), and [Re(N-N)(CO)3 (py-4-CH2-NH-cap-NH-biotin)](PF6) (py-4-CH2-NH-cap-NH-biotin = 4-(N-((6-biotinamido)hexanoyl)aminomethyl)pyridine; N-N = phen (1c), Me4-phen (2c), Me2-Ph(2)-phen (3c), dpq (4c)). Upon irradiation, all of the rhenium(I)-biotin complexes exhibited intense and long-lived triplet metal-to-ligand charge-transfer (3MLCT) (d pi(Re) --> pi* (diimine)) emission in fluid solutions at 298 K. The interactions of these biotin-containing complexes with avidin have been studied by 4'-hydroxyazobenzene-2-carboxylic acid (HABA) assays, emission titrations, and competitive association and dissociation assays. On the basis of the results of these experiments, homogeneous assays for biotin and avidin have been designed.     

Pyridinone oxovanadium(IV) complexes: a new class of insulin mimetic compounds

Transition Metal Chemistry -     

Tridentate bipyrazole compounds with a side-arm as a new class of antitumor agents

Eight tridentate bipyrazole derivatives with different side arms have been prepared in one step and with good yields. The products were screened for their cytotoxic activity against three tumor cell lines—human breast cancer cell line MDA-MB231, human prostate cancer cell line PC3, and human colorectal cell line LoVo, by use of colorimetric MTT assay. Structure–activity relationships reflected the effect of substituted drugs. Among this series, two compounds had remarkable in-vitro antiproliferative activity against the LoVo cell line with IC50 values ranging from 2.6 to 2.7 μg ml^?1. All the compounds had suitable drug-like characteristics according to Lipinski’s rule.     

New insight into the DNA binding studies,In-Vitro anti-cancer activity and molecular modelling of dioxo complexes of Molybdenum(VI) and Tungsten(VI) hydroxamic acids

The present study embodies the detail of interaction of Complex 1, Bis(N-phenyl-o-methoxybenzohydroxamato)Molybdenum(VI): [N-PMBHA-Mo(VI)] and Complex 2, Bis(N-phenylbenzohydroxamato)Tungsten(VI): [N-PBHA-W(VI)] with ct-DNA (Calf thymus-DNA) and its consequences by UV–Visible absorption spectroscopy, fluorescence spectroscopy, three-dimensional fluorescence spectroscopy, viscosity measurements and molecular docking. The intrinsic binding constant, K_b of complexes were determined which follows the order as complex 1 > complex 2 along with variation in shift and intensity for the complexes. Fluorescence spectroscopy applied for the determination of Stern–Volmer quenching constant, binding constant and the number of binding sites which reveals groove mode of binding. Non-radiative energy transfer between donor and acceptor molecule exposed by Förster energy transference theory (FRET) studies. The increase in the relative viscosity of ct-DNA with increasing the concentration of the complex 1 and complex 2 is also revealed. FTIR analysis also revealed that both the complexes interacted positively with bases and phosphates of ct-DNA. The docking studies complemented the experimental results revealing minor groove mode of binding for both the complexes. Finally, the in-vitro cytotoxicity studies indicate that the complexes have excellent anticancer activity against the breast cancer cell line, MCF-7, which could be a constructive guideline to produce new generations of anticancer agents.